Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2012
09/06/2012US20120225838 Anti-tumor effect potentiator
09/06/2012US20120225837 Medicinal agent for disease associated with epstein-barr virus, and method for screening of the medicinal agent
09/06/2012US20120225836 Compositions comprising decitabine and tetrahydrouridine and uses thereof
09/06/2012US20120225826 Transporters Comprising Spaced Arginine Moieties
09/06/2012US20120225825 Cyclodextrin-based polymers for therapeutic delivery
09/06/2012US20120225136 Inhibition of tumour cell migration
09/06/2012US20120225133 Use of an agent that restores tissue perfusion and oxygenation
09/06/2012US20120225128 Method for carrying therapeutic substances into cells
09/06/2012US20120225123 Use of Synergistic Combinations of an Avermectin and an Antineoplastic Compounds for the Treatment of Hematological Malignancies
09/06/2012US20120225118 Compositions for delivery of insoluble agents
09/06/2012US20120225117 Process for production of w/o/w emulsion, process for production of liposome employing the process, and porous membrane for use in the processes
09/06/2012US20120225115 Methods and Compositions for Improved Deliver, Expression or Activity of RNA Interference Agents
09/06/2012US20120225114 Modifying Macrophage Phenotype for Treatment of Disease
09/06/2012US20120225099 Compositions for and methods of activating guanylyl cyclase c
09/06/2012US20120225097 Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah)
09/06/2012US20120225090 Methods for enhancing antigen-specific immune responses
09/06/2012US20120225089 Novel conjugates, preparation thereof, and therapeutic use thereof
09/06/2012US20120225088 Compositions and methods for treating cancer and other diseases
09/06/2012US20120225086 Binding molecules to the human ox40 receptor
09/06/2012US20120225081 Vegf-binding molecules
09/06/2012US20120225076 Fra-1 target genes as drug targets for treating cancer
09/06/2012US20120225073 Isolation and Use of Melanoma Cancer Stem Cells
09/06/2012US20120225069 Use of a compound for reducing the biological effectiveness of il-6
09/06/2012US20120225067 Composition and Method for Mediating an Immune Response
09/06/2012US20120225064 Sphingosine 1-Phosphate Antagonism
09/06/2012US20120225063 Treatment response to anti-angiogenic therapies
09/06/2012US20120225062 Novel kinase inhibitors
09/06/2012US20120225061 Tetrasubstituted cyclohexyl compounds as kinase inhibitors
09/06/2012US20120225060 Anti-il-6 receptor antibodies and methods of use
09/06/2012US20120225059 Novel Agents and Uses Thereof
09/06/2012US20120225058 Novel immunoglobulin insertions, deletions, and substitutions
09/06/2012US20120225057 Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
09/06/2012US20120225054 Use of legume extracts for inducing and enhancing autophagy and apoptosis and for preventing and/or treating cancers
09/06/2012US20120225043 Enhancement of Immune Responses By 4-1BB-Binding Agents
09/06/2012US20120225034 Agents useful in treating facioscapulohumeral muscular dystrophy
09/06/2012US20120225030 Uses of mammalian cytokine; related reagents
09/06/2012US20120225027 Toxicity enhancing compounds and methods
09/06/2012US20120225021 Stable colloidal gold nanoparticles with controllable surface modification and functionalization
09/06/2012US20120225017 Mixed micelles
09/06/2012US20120225016 Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
09/06/2012US20120225014 Antibodies to cd40
09/06/2012US20120225013 Anti-mesothelin antibodies and immunoconjugates
09/06/2012US20120225012 Composition for hard tissue repair
09/06/2012US20120225011 Glassy compositions
09/06/2012DE112010003084T5 Fulvestrant in einer Dosierung von 500 mg zur Behandlung von fortgeschrittenem Brustkrebs Fulvestrant at a dosage of 500 mg for the treatment of advanced breast cancer
09/05/2012EP2495569A1 Method for determination of sensitivity to anti-cancer agent
09/05/2012EP2495568A1 Method for determining sensitivity to an anticancer agent
09/05/2012EP2495561A1 Anticancer agent sensitivity-determining marker
09/05/2012EP2495324A2 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
09/05/2012EP2495319A1 INTEGRIN alpha8beta1-SPECIFIC MONOCLONAL ANTIBODY
09/05/2012EP2495257A2 Dual variable domain immunoglobulin and uses thereof
09/05/2012EP2495244A1 Piperidinyl benzoimidazole derivatives as mPGEs-1 inhibitors
09/05/2012EP2495243A1 Novel 5-fluorouracil derivative
09/05/2012EP2495016A1 Bicyclic Heteroaryl Compounds
09/05/2012EP2494971A1 Gambogic acid derivatives, preparative methods and uses thereof
09/05/2012EP2494969A1 Pharmaceutical formulations of HDAC inhibitors
09/05/2012EP2494960A1 Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt
09/05/2012EP2494957A1 Submicro emulsion of paclitaxel using steroid complex as intermediate carrier
09/05/2012EP2494956A1 Paclitaxel/steroidal complex
09/05/2012EP2494038A1 Method for proliferation of antigen-specific t cells
09/05/2012EP2493910A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
09/05/2012EP2493897A1 Hydroxy-substituted gold(iii) porphyrin complexes as histone deacetylase inhibitors
09/05/2012EP2493896A1 Pharmaceutical composition containing cyclometalated n-heterocyclic carbene complexes for cancer treatment
09/05/2012EP2493895A1 N-containing heteroaryl derivatives as jak3 kinase inhibitors
09/05/2012EP2493879A2 Dimeric smac mimetics
09/05/2012EP2493865A2 Raf inhibitor compounds and methods of use thereof
09/05/2012EP2493864A1 N-oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea
09/05/2012EP2493862A1 Imidazole derivatives as ido inhibitors
09/05/2012EP2493858A1 Androgen receptor modulating compounds
09/05/2012EP2493857A1 9-aminoacridine derivatives, their preparation and uses
09/05/2012EP2493851A2 Closthioamides
09/05/2012EP2493486A1 Use of autologous effector cells and antibodies for treatment of multiple myeloma
09/05/2012EP2493485A1 Use of autologous effector cells for treatment of multiple myeloma
09/05/2012EP2493481A1 Anti-cancer composition comprising alginate
09/05/2012EP2493466A1 Novel antitumoral use of cabazitaxel
09/05/2012EP2493460A1 Methods and compositions for treating cancer
09/05/2012EP2493313A1 Kinase inhibitors
09/05/2012CN1984996B Replication competent viruses capable of silencing virus inhibitory factor expression
09/05/2012CN1918148B Substituted benzimidazoles and their use for inducing apoptosis
09/05/2012CN1905897B Antagonist anti-CD40 monoclonal antibodies and methods for their use
09/05/2012CN1679934B Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
09/05/2012CN1639569B Methods and compositions for inducing an immune response
09/05/2012CN1520424B Immunoglobulins 2
09/05/2012CN1165483B Compositions of ciplatin in comination with 2,2'-dithio-bis (ethanesulfonate) (dinesna)
09/05/2012CN102656268A Development of universal cancer drugs and vaccines
09/05/2012CN102656186A Therapeutic agents
09/05/2012CN102656179A Bufalin derivatives, pharmaceutical compositions and use thereof
09/05/2012CN102656172A 8-oxodihydropurine derivative
09/05/2012CN102656168A Polycyclic compounds as lysophosphatidic acid receptor antagonists
09/05/2012CN102656163A Heterocyclic compounds for the inhibition of PASK
09/05/2012CN102656142A Substituted benzosulphonamides
09/05/2012CN102653783A Application of HVEM (herpesvirus entry mediator) gene in preparing product for liver cancer diagnosis and prognosis prediction
09/05/2012CN102653762A Gene with function of inhibiting proliferation of gastric cancer cell BGC-823 and preparation method of gene
09/05/2012CN102653567A Extracting process of cordyceps sinensis mycelium polysaccharide of composite preparation for preventing tumor
09/05/2012CN102653548A Targeted antineoplastic compound and preparation method and application thereof
09/05/2012CN102653526A 2, 3-diaryl thiazolinone compound and usage thereof in preparation of medicine for treating tumour
09/05/2012CN102653522A Omega-carboxy-substituted diphenylthiourea compounds, and preparation method and application thereof
09/05/2012CN102653521A Piperazine thiocarbohydrazide derivate of indole-2-ketone and preparation method and application of piperazine thiocarbohydrazide derivate
09/05/2012CN102653515A Polycationic compounds and uses thereof
09/05/2012CN102653514A Chlorogenic acid analog, and preparation method and application thereof
1 ... 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 ... 2211